ASP

TSX:ASP

Acerus Pharmaceuticals Corporation

  • Stock

0.36

CAD last updated 25/07 01:50:18

Last Close

0.36

26/01 15:39

Market Cap

2.77M

Beta: 1.03

Volume Today

1.25K

Avg: 1.30K

PE Ratio

−0.09

PFCF: −0.10

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; and Noctiva, a vasopressin analog indicated for the treatment...Show More

    Earnings

    Earnings per Share (Estimate*)

    -6-5-4-3-2-12016-03-022018-03-202020-03-032021-03-302022-03-30

    Revenue (Estimate*)

    -5M5M10M2016-03-022018-03-202020-03-032021-03-302022-03-30

    *Estimate based on analyst consensus